 |
|
Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose
Suzanne Craft, PhD;
Sanjay Asthana, MD;
John W. Newcomer, MD;
Charles W. Wilkinson, PhD;
Iris Tio Matos, MD;
Laura D. Baker, PhD;
Monique Cherrier, PhD;
Cassin Lofgreen, RN;
Shawn Latendresse;
Andreana Petrova;
Stephen Plymate, MD;
Murray Raskind, MD;
Karla Grimwood, MS;
Richard C. Veith, MD
Arch Gen Psychiatry. 1999;56:1135-1140.
Background Increasing plasma glucose levels improves memory in patients with Alzheimer disease (AD). Increasing plasma glucose levels also increases endogenous insulin levels, raising the question of whether memory improvement is due to changes in insulin, independent of hyperglycemia. We address this question by examining memory and counterregulatory hormone response during hyperglycemia when endogenous insulin was suppressed by concomitant infusion of the somatostatin analogue octreotide (Sandostatin).
Methods Twenty-three patients with AD and 14 similarly aged healthy adults participated in 4 metabolic conditions on separate days: (1) hyperinsulinemia (538 pmol/L) with fasting glucose (5.6 mmol/L [100 mg/dL]), achieved by insulin and variable dextrose infusion; (2) hyperglycemia (12.5 mmol/L [225 mg/dL]) with fasting insulin (57 pmol/L), achieved by dextrose and somatostatin (octreotide) infusion (150 mg/h); (3) placebo with isotonic sodium chloride solution (saline) infusion (fasting insulin and glucose); and (4) an active control condition in which somatostatin alone was infused (150 mg/h). Declarative memory (story recall) and selective attention (Stroop interference test) were measured during steady metabolic states.
Results Patients with AD showed improved memory during hyperinsulinemia relative to placebo (P = .05) and relative to hyperglycemia (P<.005). Memory did not improve during hyperglycemia when insulin was suppressed. Somatostatin analogue infusion alone also improved memory for patients with AD (P<.05). Hyperinsulinemia increased cortisol levels in subjects with AD, whereas somatostatin alone lowered cortisol concentrations.
Conclusions These results confirm that elevated insulin without hyperglycemia enhances memory in adults with AD, and indicate that insulin is essential for hyperglycemic memory facilitation. These results also suggest a potential therapeutic role for somatostatin in AD.
From the Geriatric Research, Education, and Clinical Center (Drs Craft, Asthana, Wilkinson, Tio Matos, Baker, Cherrier, Plymate, and Veith, and Messrs Lofgreen and Latendresse, and Mss Petrova and Grimwood), Mental Health Service (Dr Raskind), Veterans Affairs Puget Sound Health Care System, Seattle, Wash; the Departments of Psychiatry and Behavioral Sciences (Drs Craft, Wilkinson, Baker, Cherrier, Raskind, and Veith and Ms Grimwood) and Medicine (Drs Asthana and Plymate), University of Washington School of Medicine, Seattle; and the Department of Psychiatry, Washington University School of Medicine, St Louis, Mo (Dr Newcomer).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Diabetes-Associated Cognitive Impairment Is Improved by a Calcium Channel Blocker, Nifedipine
Tsukuda et al.
Hypertension 2008;51:528-533.
ABSTRACT
| FULL TEXT
Toward a Model of Memory Enhancement in Schizophrenia: Glucose Administration and Hippocampal Function
Stone and Seidman
Schizophr Bull 2008;34:93-108.
ABSTRACT
| FULL TEXT
Peripheral insulin and brain structure in early Alzheimer disease
Burns et al.
Neurology 2007;69:1094-1104.
ABSTRACT
| FULL TEXT
Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance: The Cerebral Basis for Impaired Control of Food Intake in Metabolic Syndrome?
Anthony et al.
Diabetes 2006;55:2986-2992.
ABSTRACT
| FULL TEXT
Insulin Resistance in Cognitive Impairment: The InCHIANTI Study
Geroldi et al.
Arch Neurol 2005;62:1067-1072.
ABSTRACT
| FULL TEXT
Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology
Beeri et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:471-475.
ABSTRACT
| FULL TEXT
Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention
Zhao et al.
J. Neurosci. 2004;24:11120-11126.
ABSTRACT
| FULL TEXT
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arvanitakis et al.
Arch Neurol 2004;61:661-666.
ABSTRACT
| FULL TEXT
Carbohydrate-Induced Memory Impairment in Adults With Type 2 Diabetes
Greenwood et al.
Diabetes Care 2003;26:1961-1966.
ABSTRACT
| FULL TEXT
Insulin increases CSF A{beta}42 levels in normal older adults
Watson et al.
Neurology 2003;60:1899-1903.
ABSTRACT
| FULL TEXT
Axons Guided by Insulin Receptor in Drosophila Visual System
Song et al.
Science 2003;300:502-505.
ABSTRACT
| FULL TEXT
Muscarinic Potentiation of GABAA Receptor Currents Is Gated by Insulin Signaling in the Prefrontal Cortex
Ma et al.
J. Neurosci. 2003;23:1159-1168.
ABSTRACT
| FULL TEXT
Incorporating the Results of Diabetes Research Into Clinical Practice: Celebrating 25 years of Diabetes Research and Training Center translation research
Clark et al.
Diabetes Care 2001;24:2134-2142.
FULL TEXT
Dietary protein, carbohydrate, and fat enhance memory performance in the healthy elderly
Kaplan et al.
Am. J. Clin. Nutr. 2001;74:687-693.
ABSTRACT
| FULL TEXT
Immunology of delirium: new opportunities for treatment and research
BROADHURST and WILSON
Br. J. Psychiatry 2001;179:288-289.
FULL TEXT
Reply to UN Das
Kaplan et al.
Am. J. Clin. Nutr. 2001;74:410-411.
FULL TEXT
Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition
Buccafusco and Terry
J. Pharmacol. Exp. Ther. 2000;295:438-446.
ABSTRACT
| FULL TEXT
|
